Manage subscriptions   |   FAQ   |   Report Bugs/Errors/Omissions to ors@sfu.ca
17 entries found

National Institutes of Health (NIH, US)

Filter By:
  • Topic
  • Deadline
  • Region
Sort By:
  • Title
  • Deadline
  • Maximum Award

Sorry, no opportunities were found, please adjust your filters or try another search

20230616
275000

NIH Exploratory/Developmental Research Grant Program (Parent R21) International Verified Date 9 9 days until deadline

Deadline: Continuous
Maximum Award: $275,000 CAD

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

20230705

NIH Research Project Grant Program (R01) International Verified Date 28 28 days until deadline

Deadline: Continuous

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

20230716
275000

NIH Exploratory/Developmental Research Grant Program (Parent R21) International Verified Date 39 39 days until deadline

Deadline: Continuous
Maximum Award: $275,000 CAD

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

20230802
625000

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) International Verified Date 56 56 days until deadline

Deadline: August 02, 2023
Maximum Award: $625,000 USD

Topics of interest for this program cover a broad range of infectious diseases research topics, including, but not limited to: tuberculosis, malaria, HIV/AIDS, parasitic diseases, vectors and vector-borne diseases, drug resistance (antimicrobial and/or insecticide), zoonoses with public health consequences, and other emerging and re-emerging infectious diseases that are of public health significance. Development of basic, immunological, microbiological, biostatistical, bioinformatics, genomics, epidemiological, data management, and clinical research capacity is encouraged.

20231005

NIH Research Project Grant Program (R01) International Verified Date

Deadline: Continuous

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

20231005

National Heart, Lung, and Blood Institute (NHLBI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

20231016
275000

NIH Exploratory/Developmental Research Grant Program (Parent R21) International Verified Date

Deadline: Continuous
Maximum Award: $275,000 CAD

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

20231105

NIH Research Project Grant Program (R01) International Verified Date

Deadline: Continuous

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

20231116
275000

NIH Exploratory/Developmental Research Grant Program (Parent R21) International Verified Date

Deadline: Continuous
Maximum Award: $275,000 CAD

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

20240216
275000

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

20240305

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

20240316
275000

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

20240605

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

99991231

NIH offers funding for many types of grants and contracts.

99991231

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337).


x